0001209191-17-030369.txt : 20170505 0001209191-17-030369.hdr.sgml : 20170505 20170505165049 ACCESSION NUMBER: 0001209191-17-030369 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170504 FILED AS OF DATE: 20170505 DATE AS OF CHANGE: 20170505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP CENTRAL INDEX KEY: 0000917520 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 510317849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 BUSINESS PHONE: 6092750500 MAIL ADDRESS: STREET 1: 311 ENTERPRISE DRIVE CITY: PLAINSBORO STATE: NJ ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP DATE OF NAME CHANGE: 19950614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN JAMES M CENTRAL INDEX KEY: 0001210128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26224 FILM NUMBER: 17819092 MAIL ADDRESS: STREET 1: 311 ENTERPRISE DR CITY: PLAINSBORO STATE: NJ ZIP: 08536 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-04 0 0000917520 INTEGRA LIFESCIENCES HOLDINGS CORP IART 0001210128 SULLIVAN JAMES M 311 C ENTERPRISE DR PLAINSBORO NJ 08536 1 0 0 0 Common Stock 2017-05-04 4 M 0 15658 10.74 A 70154 D Common Stock 2017-05-04 4 S 0 15658 45.8918 D 54496 D Non-Qualified Stock Option (right to buy) 10.74 2017-05-04 4 M 0 15658 0.00 D 2017-05-20 Common Stock 15658 0 D The price shown above represents the weighted average price of the shares sold. The range of sale prices was $45.83 to $45.97. 25% of the stock options vest every quarter from the grant date of 05/20/2009. This stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. /s/ Richard D. Gorelick; Attorney-in-Fact 2017-05-05